Replies to post #16364 on Amarin Corp Plc (AMRN)

[exwannabe]

It is not about REDUCE-IT

The FDA has clearly put the issue of trigs being a valid surrogate endpoint in play. They have an entire large section of the brief devoted to the subject.

They are not discussing this issue for fun.